Between roughly 2011 and 2015, the Russian state operated a doping program without precedent in sport: not the cheating of individual athletes, but an institutional system run by the Ministry of Sport, the security services, and an accredited national laboratory, designed to make positive drug tests disappear. It reached its most audacious form at the 2014 Winter Olympics in Sochi, on Russian soil, where dirty urine samples were physically swapped for clean ones overnight. The verdict, handed down by sporting authority and upheld on appeal, was: banned. Russia was barred from competing under its own flag, name, and anthem at the Olympics and major world championships.
The mechanism was uncovered chiefly through Dr. Grigory Rodchenkov, the former director of Russia’s anti-doping laboratory, who had helped build the system and then turned whistleblower. The World Anti-Doping Agency commissioned an independent investigation led by Canadian law professor Richard McLaren, whose two-part report in 2016 concluded, beyond reasonable doubt, that Russia operated a state-directed scheme it called the “disappearing positive methodology.” More than 1,000 athletes across more than 30 sports were found to have benefited.
The Sochi method was the report’s most striking finding. The supposedly tamper-proof sample bottles could be opened with a tool; late at night, after foreign observers had left, tainted samples were passed through a concealed hole in the laboratory wall to a room controlled by the security service, swapped for clean samples banked months earlier, and resealed. A control system built to be inviolable was defeated by a hole in a wall.
The reckoning was protracted and, by design, partial. WADA declared the Russian anti-doping agency, RUSADA, non-compliant; in December 2019 it imposed a four-year package of sanctions, which the Court of Arbitration for Sport in December 2020 upheld in principle but reduced to two years, running to the end of 2022. Russian athletes who could demonstrate they were clean were permitted to compete as neutrals, without flag or anthem — a compromise that punished a state while sparing individuals, and that satisfied almost no one, least of all the clean athletes of other nations who had lost medals, finals, and moments they could never recover.
Maria Sharapova, the five-time Grand Slam champion and for eleven straight years the world’s highest-earning female athlete, was banned for doping in 2016 — not for a steroid or a transfusion, but for a Latvian heart drug she had been taking openly for a decade, which the World Anti-Doping Agency had added to its prohibited list on the first day of that year. She tested positive at the Australian Open in January; the International Tennis Federation banned her two years in June; and on appeal the Court of Arbitration for Sport cut the sanction to fifteen months in October 2016, holding that she had not cheated on purpose but had still failed to do the one thing required of her — check whether her medication was still legal.
The substance was meldonium, sold under the brand name Mildronate, manufactured in Latvia and prescribed across the former Soviet bloc. Sharapova said a family doctor had put her on it in 2006 for a cluster of complaints — frequent illness, irregular EKG readings, a family history of diabetes. WADA banned it effective January 1, 2016, on evidence that athletes were using it to aid endurance and recovery. Sharapova kept taking it, and on January 26, 2016, a sample at the Australian Open came back positive. She had, in the most literal sense, been doping with a drug she had declared to no one because she had stopped reading the list that now contained it.
What makes the case unusual is how little of it turned on chemistry and how much on paperwork. Nobody disputed what was in her system or why. The fight was entirely about fault — how careless an athlete has to be, and how clearly a federation has to warn, before a positive for a newly banned drug becomes two years rather than fifteen months. The CAS panel found fault on both sides, hers for not checking and the testers’ for burying the change in a wall of email, and split the difference.
It cost her the back half of a season, a chunk of her ranking, and the immediate suspension of contracts with Nike, Porsche, and TAG Heuer. It did not cost her a Grand Slam title; the only result disqualified was her quarter-final at the 2016 Australian Open. The verdict on record is a ban, and a relatively short one, for the rarest kind of doping case: the athlete caught by a change of rules rather than a change of behaviour.
Kamila Valieva was fifteen years old when she skated at the 2022 Beijing Winter Olympics, and fifteen when a sample she had given six weeks earlier was revealed, mid-Games, to contain a banned heart medication. On January 29, 2024, the Court of Arbitration for Sport found that she had committed an anti-doping rule violation, imposed a four-year ban backdated to December 25, 2021, and disqualified all of her results from that date — including the Olympic team event in which she had skated for the Russian Olympic Committee. As a consequence, the ROC’s team gold was lost: the International Skating Union re-ranked the event, elevating the United States to gold and Japan to silver.
The substance was trimetazidine, an anti-anginal drug that improves cardiac efficiency and is banned in sport. The sample was collected on December 25, 2021, at the Russian national championships by RUSADA. The result should have been processed in days. Instead the WADA-accredited Stockholm laboratory did not report the positive until February 8, 2022 — after Valieva had already helped the ROC win the team event in Beijing. The timing detonated the Games’ most painful controversy, and it was a failure of the adult laboratory and reporting system, not of the child who had given the sample.
Because she was fifteen, Valieva was a “protected person” under the World Anti-Doping Code — a category created to shield minors, who cannot reasonably be held to an adult’s standard of personal responsibility, and to direct scrutiny toward the coaches, doctors, and officials around them. A CAS ad hoc panel cited that status during the Games in allowing her to keep competing; the final ruling two years later still imposed the standard four-year sanction, holding that her protected status did not eliminate the consequence. But the question her case forced was never really about a teenager’s culpability. It was about the system of adults that put a banned drug into the body of a child and then took six weeks to say so — and this dossier aims its scrutiny where it belongs, at the entourage and the institutions. The skater at the centre was a minor, the person the Code exists to protect.
Sun Yang, the most decorated swimmer China has produced and a three-time Olympic champion, was banned in 2021 for four years and three months — not for a drug found in his body, but for what happened to a vial of his blood. On the night of 4 September 2018, anti-doping officials arrived at his home to collect samples. By the time they left, a container holding his blood had been smashed with a hammer, and the case the testers had come to fill went unfilled. The verdict on record is a refusal-and-tampering sanction handed down by the Court of Arbitration for Sport, not a positive test, and the distinction is the whole story.
The mechanism was almost defiantly simple. Sun and his entourage disputed the credentials of the doping-control personnel; an argument escalated; and rather than let the sample leave with testers he deemed unauthorized, a member of his camp used a hammer to break open the container so the blood could not be carried away. Under the World Anti-Doping Code, destroying or tampering with a sample is itself an anti-doping rule violation, treated as seriously as a positive result. An athlete does not get to adjudicate the legitimacy of his own drug test in real time and then dismantle the evidence when he loses the argument.
The case then took a detour that few doping disputes ever take. CAS first banned Sun for eight years in February 2020 — the maximum available. He appealed to the Swiss Federal Tribunal, which in December 2020 set that ruling aside, not on the facts but because the chairman of the arbitration panel had posted offensive social-media comments that gave objectively justified doubts about his impartiality. The case went back for a fresh hearing before a new panel, which in June 2021 reached the same conclusion on the merits and reduced the ban to four years and three months, treating it as Sun’s second violation.
What it cost him was the prime of a career. The ban, calculated to run from the date of the original award, kept Sun out of the Tokyo Olympics, where he would have defended his 200-metre freestyle title. He did not return to eligibility until May 2024, by then in his thirties. He lost no medals to disqualification, because the offence was not a doping positive that invalidated a result. He lost something harder to award to a runner-up: the years.
In 2015 the entire Bulgarian national weightlifting team was banned from the 2016 Rio Olympics, the punishment for a single, staggering season in which eleven of its lifters tested positive for the same anabolic steroid. The International Weightlifting Federation declared Bulgaria ineligible for the Games in November 2015, and when the federation appealed, the Court of Arbitration for Sport upheld the exclusion. It was not the punishment of one cheating athlete; it was the suspension of a program, and the program had earned it.
The mechanism was both crude and collective. Eight men and three women — eleven lifters in all — returned positives for stanozolol, a familiar anabolic steroid, in a cluster of tests around March 2015 as the team prepared for that year’s European Championships. The IWF’s anti-doping regime carried a specific tripwire for exactly this situation: when a national federation accumulates a defined number of positives within a single year — at least nine — the federation itself, not merely its individual athletes, can be sanctioned. Bulgaria sailed past the threshold with two to spare, and the rule did what it was written to do. Rather than ban eleven names and let the next eleven take their places at the platform, the IWF banned the country.
What made the case more than a one-season embarrassment was the file behind it. Bulgaria had been here before, repeatedly. The team was sent home in disgrace from the 2000 Sydney Olympics, where it was stripped of three medals after a cascade of furosemide positives — the diuretic favoured as a masking agent — including the gold of Izabela Dragneva, who became the first female weightlifter ever stripped of an Olympic title. Bulgaria then withdrew its team before the 2008 Beijing Games rather than face the consequences of yet another doping cluster. The 2015 ban was not a first offence by a clean nation that slipped; it was the latest entry in a recidivist ledger that stretched across three Olympic cycles.
The cost was a clean sweep of opportunity. An entire generation of Bulgarian lifters — including former European champions — lost the chance to compete in Rio not for their own individual results but because the system they trained inside had failed too many times to be trusted at an Olympics. CAS confirmed the principle while trimming the edges: it upheld the Olympic ban but set aside a 500,000-dollar fine the IWF had attached. The medals stayed lost, the Games stayed closed, and the bill got smaller.
Operación Puerto was the Spanish police investigation that, in May 2006, cracked open the blood-doping ring run by the Madrid sports doctor Eufemiano Fuentes — and produced a paradox that still defines it. The athletes who used the ring were banned; the doctor who ran it walked free. When the Guardia Civil raided Fuentes’s premises they found roughly two hundred coded bags of frozen blood and plasma, a refrigerated library of athletes’ own blood waiting to be reinfused at the competition moments that mattered. The sporting verdicts followed over several years; the criminal verdict against Fuentes was overturned on a legal technicality so tidy it has become the case’s epitaph.
The mechanism was autologous blood doping — the oldest trick in endurance sport, modernized into a service. An athlete’s blood would be withdrawn, stored, and reinfused later to raise the red-cell count and the oxygen-carrying capacity that cycling lives on, often alongside EPO. Because the reinfused blood was the athlete’s own, it left little for a standard test to catch; the evidence was not in the rider’s veins on test day but in Fuentes’s freezers, labelled with code names. “Puerto,” fittingly for a cycling scandal, is Spanish for a mountain pass — the operation was, in effect, Operation Mountain Pass. The code names became the case’s grim parlour game: bags marked “Jan” or numbered identifiers were matched by DNA to specific riders.
The sporting reckoning, when it came, was real. Jan Ullrich, the 1997 Tour de France champion, was banned for two years by the Court of Arbitration for Sport in February 2012, with his results from May 2005 to his 2007 retirement annulled — including his third place at the 2005 Tour. Ivan Basso, identified by the code name “Birillo” (the name of his dog), was suspended after admitting involvement and pulled from the 2006 Giro. Alejandro Valverde, linked by DNA to a bag, was banned for two years by CAS on a worldwide basis, backdated to January 2010. The ring’s clients paid in suspensions and erased palmarès.
Fuentes did not. A Madrid court convicted him in 2013 of a public-health offence — a one-year suspended sentence plus a four-year ban from sports medicine — and ordered the bags of blood destroyed. In June 2016 a higher Madrid court acquitted him outright, reasoning that a person’s own blood reinfused into that person is not a “substance” endangering public health under the statute, and noting the inconvenient truth that doping was not a crime in Spain when the ring operated. WADA and the UCI had to fight just to stop the evidence being incinerated. The doctor went free; the blood, very nearly, went into the furnace.
Justin Gatlin, the American sprinter who won the Olympic 100m in Athens in 2004, was banned from athletics in 2006 after testing positive for testosterone, a sanction that annulled the 9.77-second world record he had set weeks earlier and, because it counted as his second doping offence, very nearly ended his career for good. The United States Anti-Doping Agency initially announced an eight-year ban — a near-lifetime penalty for a sprinter then 24 — which an arbitration panel reduced to four years in December 2007. Gatlin returned to competition in August 2010, and then did the thing the sport could not metabolize: he won. Olympic bronze in 2012, Olympic silver in 2016, and a world title in 2017 in which he beat Usain Bolt in Bolt’s final individual race. The medals were legitimate. The booing that greeted them was a verdict the rule book could not impose.
The 2006 case was, on its face, simple. An in-competition test at the Kansas Relays on April 22, 2006 returned positive for testosterone or its precursors. The B-sample confirmed it that July. The complication was history. Five years earlier, as a freshman at the University of Tennessee, Gatlin had tested positive for an amphetamine at the 2001 US junior championships — a finding traced to Adderall he had taken since childhood for attention-deficit disorder. An arbitration panel at the time called him “certainly not a doper” and the violation “at most, a technical or a paperwork” matter, and the IAAF granted early reinstatement on the strength of the medical explanation. It was, by any reasonable reading, the least sinister positive test imaginable. Under the rules, it was still a first offence.
That technicality governed everything that followed. A first amphetamine positive plus a testosterone positive is, in anti-doping arithmetic, a repeat offender, and the testosterone case therefore carried the weight of a second strike regardless of how innocuous the first had been. Gatlin’s camp blamed a massage therapist for rubbing a testosterone cream onto him without his knowledge — an explanation never substantiated — but the substance, the test, and the prior record were not in dispute. The eight-year ban reflected the recidivism; the reduction to four reflected his cooperation and the genuine ambiguity of the 2001 case.
What the verdict could not settle was the matter of forgiveness. Gatlin served his time, came back, and ran faster in his thirties than most men do in their twenties, which left the sport in an awkward position: he had paid the penalty the system prescribed and was therefore entitled to compete, yet he was treated as the ban had never lifted. The crowds booed an athlete who was, by the rules’ own logic, rehabilitated. His career became the test case for a question the sport has never resolved — whether a served sentence is a clean slate, or merely permission to be hated in public.